Charles Schwab Investment Management Inc. acquired a new position in shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 26,852 shares of the company's stock, valued at approximately $544,000.
Other large investors have also recently bought and sold shares of the company. Bank of New York Mellon Corp acquired a new stake in shares of Guardian Pharmacy Services in the 4th quarter valued at $276,000. New York State Common Retirement Fund grew its position in Guardian Pharmacy Services by 17.9% in the fourth quarter. New York State Common Retirement Fund now owns 278,548 shares of the company's stock valued at $5,643,000 after acquiring an additional 42,368 shares during the last quarter. Rhumbline Advisers acquired a new position in Guardian Pharmacy Services during the fourth quarter worth about $149,000. Compass Financial Services Inc bought a new position in shares of Guardian Pharmacy Services in the fourth quarter worth about $58,000. Finally, Calamos Advisors LLC boosted its stake in shares of Guardian Pharmacy Services by 124.7% in the 4th quarter. Calamos Advisors LLC now owns 24,725 shares of the company's stock valued at $501,000 after purchasing an additional 13,720 shares in the last quarter.
Guardian Pharmacy Services Trading Down 1.8 %
Shares of Guardian Pharmacy Services stock traded down $0.38 during midday trading on Friday, hitting $21.16. 132,347 shares of the company traded hands, compared to its average volume of 157,089. The business has a fifty day simple moving average of $20.56. Guardian Pharmacy Services, Inc. has a 12 month low of $14.16 and a 12 month high of $25.74.
About Guardian Pharmacy Services
(
Free Report)
Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.
Recommended Stories
Before you consider Guardian Pharmacy Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Guardian Pharmacy Services wasn't on the list.
While Guardian Pharmacy Services currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn how options trading can help you navigate market volatility, manage risk, and maximize returns with MarketBeat's "Unlock the Potential in Options Trading." Click the link below to have this special report delivered to your inbox.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
